Previous 10 | Next 10 |
Shares of small-cap biotech Inovio Pharmaceuticals ( NASDAQ: INO ) gained as much as 14.3% to $2.45 in Wednesday afternoon trading, after it reported a Q3 profit beat and extended its cash runway projections. The gains continue a recent strong run for the stock, which is...
Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q3 2022 Earnings Call Nov 08, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. (INO) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Thomas Hong – Manager-Investor Communications Jacque Shea – President and Chief Executive Officer Michael Sumner – Chief Medi...
The following slide deck was published by Inovio Pharmaceuticals, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Inovio Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation
Inovio Pharmaceuticals press release ( NASDAQ: INO ): Q3 GAAP EPS of -$0.15 beats by $0.15 . Revenue of $9.15M. Expects its cash runway to extend into the first quarter of 2025. For further details see: Inovio Pharmaceuticals GAAP EPS of -$0.15 beats by $...
INOVIO Reports Financial Results and Highlights for the Third Quarter 2022 PR Newswire Announced positive interim data for INO-3107 as a potential first-in-class treatment for Recurrent Respiratory Papillomatosis Advanced strategy to focus on developing candidates ...
More Short Squeeze Penny Stocks For Your November Watch List If you want to make money with penny stocks, learning how to find them and what to look for is a great first step. This article looks at a phenomenon known as a short squeeze. In this scenario, traders will bet against stocks ...
Sometimes in the biotech world, if a company pulls the plug on one of its research programs, investors respond with relief. That was the case on Friday with Inovio Pharmaceuticals (NASDAQ: INO) , following its announcement of the cessation of an experimental coronavirus booster effo...
Inovio Pharmaceuticals ( NASDAQ: INO ) on Thursday said it had discontinued development of its COVID-19 booster vaccine. Shares of the small-cap biotech fell 2.4% to $2.01 after hours. "The decision follows INOVIO's comprehensive review of its portfolio, market con...
INOVIO Provides Update on COVID-19 Heterologous Booster Vaccine Candidate, INO-4800 PR Newswire PLYMOUTH MEETING, Pa. , Oct. 27, 2022 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to h...
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLYMOUTH MEETING, Pa. , July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and ...
5G leader welcomes new Chief Product Officer, Senior Vice President Sales/Service Providers and Head of Operations Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises, and SMBs, today announced...
2024-07-16 13:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...